Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Novavax (NASDAQ:NVAX) Plunges on the Russell 2000: What Investors Watch in Rate-Driven Health Care

● Elevated Treasury yields hit long-duration and clinical-stage health-care stocks.

Nitish Kishor | 19 October 2026

Why Did Ocular Therapeutix (NASDAQ:OCUL) Fall on the Russell 2000? Biotech Slid as Yields Stayed Elevated

● The 10-year Treasury yield ended near 5.1 after topping 5.30 earlier in October.

Nitish Kishor | 19 October 2026

Omeros (NASDAQ:OMER) Fell on the Russell 2000: EU Panel Maintained Its Negative Opinion on Narsoplimab

● Omeros fell Friday after the CHMP kept its negative opinion on narsoplimab following re-examination.

Nitish Kishor | 19 October 2026

PacBio (NASDAQ:PACB) Plunges on the Russell 2000: Genomics Stocks Were Caught in the Biotech Retreat

● The drop came 11 days after a jump on an EpiSign and Geneyx partnership.

Nitish Kishor | 19 October 2026

Praxis Precision Medicines (NASDAQ:PRAX) in Focus on Nasdaq Composite as JPMorgan Starts at Overweight

● No closing move for Praxis shares was reported on Friday.

Nitish Kishor | 19 October 2026

Repligen (NASDAQ:RGEN) Falls on the S&P MidCap 400: What Investors Watch in Life-Sciences Tools Earnings

● No company announcement, filing or analyst action on Repligen was reported.

Nitish Kishor | 19 October 2026

Why Did Iambic Therapeutics (NASDAQ:IAM) Shares Surge Against a Falling Market?

Iambic Therapeutics Inc. (NASDAQ:IAM) ranked among the strongest gainers in the US market on Friday, October 16, 2026, closing at $23.81 for a daily gain of 25.91%.

Nitish Kishor | 19 October 2026

What Investors Are Watching at Strata Critical Medical (NASDAQ:SRTA) After a Light-Volume Gain

Strata Critical Medical, Inc. (NASDAQ:SRTA) closed at $4.54 on Friday, October 16, 2026, up 4.61% on the day. The small-cap advanced during a session in which the broad market fell, and the move is best explained by the trading characteristics of a lightly traded …

Nitish Kishor | 19 October 2026

Why Did Alaunos Therapeutics (NASDAQ:TCRT) Shares Spike in Thin, Speculative Trading?

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) moved sharply higher on Friday, October 16, 2026, closing at $2.630, a gain of 20.64% for the session. The advance came on a day when the broad US market was lower, with the Nasdaq Composite down 2.14% and the S&P …

Nitish Kishor | 19 October 2026
Support

Hi! How can we help you today?

Loading…